Immunome Inc. (IMNM) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Immunome Inc.

NASDAQ: IMNM · Real-Time Price · USD
10.52
0.72 (7.35%)
At close: Sep 05, 2025, 3:59 PM
10.58
0.57%
After-hours: Sep 05, 2025, 07:42 PM EDT

Immunome Revenue

Immunome reported an annual revenue of $9.04M, reflecting a -35.5% growth. For the quarter ending June 30, 2025, Immunome generated $4.01M in revenue.
Revenue (ttm)
9.04M
Revenue Growth
-35.5%
Price / Sales Ratio
68.88
Revenue / Employee
69.02K
Employees
131
Market Cap
915.71M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 9.04M -35.50%
Dec 31, 2023 14.02M +Infinity%
Dec 31, 2022 0 n/a
Dec 31, 2021 0 n/a
Dec 31, 2020 0 n/a
Dec 31, 2019 0 n/a
Dec 31, 2018 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.